Sharma Mani 4

What Happened

• Sharma Mani, SVP, Group Controller and Head of Global Finance Services at AstraZeneca, acquired 2 shares as an award under the issuer's Share Incentive Plan. The award is reported at $190.43 per share, for a total value of $381. This transaction is reported as an acquisition/award (code A).

Key Details

• Transaction date: 2026-07-06
• Report filed: 2026-07-08 (Form 4 accession 0001104659-26-081807)
• Shares acquired: 2 shares at $190.43 each; total value $381
• Share price conversion/footnote: the award represents shares issued at GBP142.492 converted to USD at GBP1 = $1.3364 (conversion published July 2, 2026)
• Shares owned after transaction: not specified in the filing
• Transaction type: Award/Grant under the company's Share Incentive Plan (code A)

Context

• This was an award under AstraZeneca’s employee/share incentive plan rather than an open‑market purchase or sale. Small awards like this (2 shares, ~$381) are routine compensation events for executives and do not, by themselves, indicate a material change in insider conviction.
• The filing provides conversion details from GBP to USD; no 10b5‑1 plan, immediate sale, tax withholding, or late‑filing flag is noted in the report.